☰

Andrea T. Hooper, Ph.D. - Publications

Affiliations: 
2009 Weill Cornell Medical College, New York, NY, United States 
Area:
Animal Physiology Biology, Immunology, Oncology
Tree Info Grants Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Westerweel PE, Teraa M, Rafii S, Jaspers JE, White IA, Hooper AT, Doevendans PA, Verhaar MC. Impaired endothelial progenitor cell mobilization and dysfunctional bone marrow stroma in diabetes mellitus. Plos One. 8: e60357. PMID 23555959 DOI: 10.1371/Journal.Pone.0060357  0.571
2010 Butler JM, Nolan DJ, Vertes EL, Varnum-Finney B, Kobayashi H, Hooper AT, Seandel M, Shido K, White IA, Kobayashi M, Witte L, May C, Shawber C, Kimura Y, Kitajewski J, et al. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell. 6: 251-64. PMID 20207228 DOI: 10.1016/J.Stem.2010.02.001  0.648
2009 Kopp HG, Hooper AT, Avecilla ST, Rafii S. Functional heterogeneity of the bone marrow vascular niche. Annals of the New York Academy of Sciences. 1176: 47-54. PMID 19796232 DOI: 10.1111/J.1749-6632.2009.04964.X  0.75
2009 Hooper AT, Shmelkov SV, Gupta S, Milde T, Bambino K, Gillen K, Goetz M, Chavala S, Baljevic M, Murphy AJ, Valenzuela DM, Gale NW, Thurston G, Yancopoulos GD, Vahdat L, et al. Angiomodulin is a specific marker of vasculature and regulates vascular endothelial growth factor-A-dependent neoangiogenesis. Circulation Research. 105: 201-8. PMID 19542015 DOI: 10.1161/Circresaha.109.196790  0.618
2009 Hooper AT, Butler JM, Nolan DJ, Kranz A, Iida K, Kobayashi M, Kopp HG, Shido K, Petit I, Yanger K, James D, Witte L, Zhu Z, Wu Y, Pytowski B, et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell. 4: 263-74. PMID 19265665 DOI: 10.1016/J.Stem.2009.01.006  0.665
2008 Seandel M, Butler JM, Kobayashi H, Hooper AT, White IA, Zhang F, Vertes EL, Kobayashi M, Zhang Y, Shmelkov SV, Hackett NR, Rabbany S, Boyer JL, Rafii S. Generation of a functional and durable vascular niche by the adenoviral E4ORF1 gene. Proceedings of the National Academy of Sciences of the United States of America. 105: 19288-93. PMID 19036927 DOI: 10.1073/Pnas.0805980105  0.644
2008 Swendeman S, Mendelson K, Weskamp G, Horiuchi K, Deutsch U, Scherle P, Hooper A, Rafii S, Blobel CP. VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling. Circulation Research. 103: 916-8. PMID 18818406 DOI: 10.1161/Circresaha.108.184416  0.609
2008 Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK, Chadburn A, Murphy AJ, Valenzuela DM, Gale NW, Thurston G, et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. The Journal of Clinical Investigation. 118: 2111-20. PMID 18497886 DOI: 10.1172/Jci34401  0.538
2008 Petit I, Karajannis MA, Vincent L, Young L, Butler J, Hooper AT, Shido K, Steller H, Chaplin DJ, Feldman E, Rafii S. The microtubule-targeting agent CA4P regresses leukemic xenografts by disrupting interaction with vascular cells and mitochondrial-dependent cell death. Blood. 111: 1951-61. PMID 18024794 DOI: 10.1182/Blood-2007-05-089219  0.587
2008 Hormigo A, Shmelkov SV, Hooper AT, Butler J, Lyden D, Rafii S. Expression of CD133+ in the brain of a mouse model with a lacZ reporter knock-in at the CD133 locus Journal of Clinical Oncology. 26: 2000-2000. DOI: 10.1200/Jco.2008.26.15_Suppl.2000  0.452
2008 Baljevic M, Shmelkov SV, Nolan DJ, Hooper AT, Hormigo A, Iyer R, Gutin PH, Rafii S. Endothelial Progenitor Cell Marker CD133 Identifies Tumor Endothelium Blood. 112: 5449-5449. DOI: 10.1182/Blood.V112.11.5449.5449  0.606
2007 Hooper AT, Butler J, Petit I, Rafii S. Does N-cadherin regulate interaction of hematopoietic stem cells with their niches? Cell Stem Cell. 1: 127-9. PMID 18371341 DOI: 10.1016/J.Stem.2007.07.012  0.542
2007 Kopp HG, Hooper AT, Shmelkov SV, Rafii S. Beta-galactosidase staining on bone marrow. The osteoclast pitfall. Histology and Histopathology. 22: 971-6. PMID 17523074  0.478
2007 Mutlu AD, Cavallin LE, Vincent L, Chiozzini C, Eroles P, Duran EM, Asgari Z, Hooper AT, La Perle KM, Hilsher C, Gao SJ, Dittmer DP, Rafii S, Mesri EA. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell. 11: 245-58. PMID 17349582 DOI: 10.1016/J.Ccr.2007.01.015  0.649
2007 D'Agostino Mutlu A, Cavallin LE, Vincent L, Chiozzini C, Eroles P, Duran EM, Asgari Z, Hooper AT, La Perle KMD, Hilsher C, Gao SJ, Dittmer DP, Rafii S, Mesri EA. In Vivo-Restricted and Reversible Malignancy Induced by Human Herpesvirus-8 KSHV: A Cell and Animal Model of Virally Induced Kaposi's Sarcoma (DOI:10.1016/j.ccr.2007.01.015) Cancer Cell. 11: 471. DOI: 10.1016/J.Ccr.2007.04.013  0.526
2006 Kopp HG, Hooper AT, Broekman MJ, Avecilla ST, Petit I, Luo M, Milde T, Ramos CA, Zhang F, Kopp T, Bornstein P, Jin DK, Marcus AJ, Rafii S. Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization. The Journal of Clinical Investigation. 116: 3277-91. PMID 17143334 DOI: 10.1172/Jci29314  0.733
2006 Ruan J, Hyjek E, Kermani P, Christos PJ, Hooper AT, Coleman M, Hempstead B, Leonard JP, Chadburn A, Rafii S. Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma Clinical Cancer Research. 12: 5622-5631. PMID 17020964 DOI: 10.1158/1078-0432.Ccr-06-1204  0.593
2006 Wu Y, Hooper AT, Zhong Z, Witte L, Bohlen P, Rafii S, Hicklin DJ. The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma. International Journal of Cancer. 119: 1519-29. PMID 16671089 DOI: 10.1002/Ijc.21865  0.594
2006 Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM, Hooper AT, Amano H, Avecilla ST, Heissig B, Hattori K, Zhang F, Hicklin DJ, Wu Y, Zhu Z, et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nature Medicine. 12: 557-67. PMID 16648859 DOI: 10.1038/Nm1400  0.716
2006 Kopp H, Hooper AT, Rafii S. Bone Marrow Osteoclasts Stain Positive with X-Gal: Implications for the Tracking of LacZ-Labelled Cells. Blood. 108: 4173-4173. DOI: 10.1182/Blood.V108.11.4173.4173  0.553
2006 Jin DK, Shido K, Kopp H, Petit I, Shmelkov SV, Young LM, Hooper AT, Amano H, Avecilla ST, Heissig B, Hattori K, Zhang F, Hicklin DJ, Wu Y, Zhu Z, et al. Erratum: Corrigendum: Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes Nature Medicine. 12: 978-978. DOI: 10.1038/Nm0806-978  0.667
2005 Hooper AT, Akiri G, Jin D, Shmelkov SV, Chuang E, Shin SJ, Wu Y, Hicklin DJ, Rafii S, Vahdat LT. VEGF receptor expression on reactive breast cancer stroma: paving the way for tumor invasion. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 9642. PMID 27943777 DOI: 10.1200/Jco.2005.23.16_Suppl.9642  0.51
2005 Kopp HG, Avecilla ST, Hooper AT, Rafii S. The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology (Bethesda, Md.). 20: 349-56. PMID 16174874 DOI: 10.1152/Physiol.00025.2005  0.72
2005 Vincent L, Jin DK, Karajannis MA, Shido K, Hooper AT, Rashbaum WK, Pytowski B, Wu Y, Hicklin DJ, Zhu Z, Bohlen P, Niesvizky R, Rafii S. Fetal stromal-dependent paracrine and intracrine vascular endothelial growth factor-a/vascular endothelial growth factor receptor-1 signaling promotes proliferation and motility of human primary myeloma cells. Cancer Research. 65: 3185-92. PMID 15833849 DOI: 10.1158/0008-5472.Can-04-3598  0.661
2005 Kopp HG, Avecilla ST, Hooper AT, Shmelkov SV, Ramos CA, Zhang F, Rafii S. Tie2 activation contributes to hemangiogenic regeneration after myelosuppression. Blood. 106: 505-13. PMID 15817675 DOI: 10.1182/Blood-2004-11-4269  0.754
2005 Fan F, Wey JS, McCarty MF, Belcheva A, Liu W, Bauer TW, Somcio RJ, Wu Y, Hooper A, Hicklin DJ, Ellis LM. Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. Oncogene. 24: 2647-53. PMID 15735759 DOI: 10.1038/Sj.Onc.1208246  0.425
2005 Ellis LR, Vincent L, Shmelkov S, Hooper A, Avecilla S, Young L, Rafii S. Expression of Vascular Endothelial-Cadherin on Leukemic Cells Mediates Their Interaction with Vascular Endothelium. Blood. 106: 2761-2761. DOI: 10.1182/Blood.V106.11.2761.2761  0.748
2005 Ruan J, Hyjek E, Hooper AT, Vincent L, Kermani P, Christos PJ, Ikalowych S, Coleman M, Hempstead B, Leonard JP, Chadburn A, Rafii S. Stromal Incorporation of VEGFR-1+, CD68+ and α-SMA+ Hemangiogenic Cells Correlates with Histologic Subtype in Non-Hodgkin’s Lymphoma. Blood. 106: 1930-1930. DOI: 10.1182/Blood.V106.11.1930.1930  0.566
2002 Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nature Medicine. 8: 831-40. PMID 12091877 DOI: 10.1038/nm731  0.387
2002 Li Y, Wang MN, Li H, King KD, Bassi R, Sun H, Santiago A, Hooper AT, Bohlen P, Hicklin DJ. Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis. The Journal of Experimental Medicine. 195: 1575-84. PMID 12070285  0.354
1999 Zagzag D, Hooper A, Friedlander DR, Chan W, Holash J, Wiegand SJ, Yancopoulos GD, Grumet M. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Experimental Neurology. 159: 391-400. PMID 10506510 DOI: 10.1006/Exnr.1999.7162  0.37
1992 Patel D, Bassi R, Hooper A, Prewett M, Hicklin DJ, Kang X. Anti-epidermal growth factor receptor monoclonal antibody cetuximab inhibits EGFR/HER-2 heterodimerization and activation. International Journal of Oncology. 34: 25-32. DOI: 10.3892/Ijo_00000125  0.334
Show low-probability matches.